DELMAR PHARMACEUTICALS (DMPI) SEC filings
DMPI SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the DMPI overview →
No DMPI SEC filing events in the measured window.
Nothing matched in the current window — the DMPI overview has every event we measure for this name.
Get an email when DMPI moves on news →Keep exploring
More DMPI: earnings → · analyst actions → · DMPI overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CAMBREX (CBM) | 505 | 0.00% | 49% |
| Celyad Oncology SA - American Depositary Shares (CYAD) | 504 | 0.00% | 41% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 504 | -0.09% | 42% |
| CORINDUS VASCULAR ROBOTICS INC (CVRS) | 503 | -0.65% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.